MyoKardia, Inc. (NASDAQ:MYOK)

About the company

MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

235

$34.00M

Total Revenue

235

Employees

$4B

Market Capitalization

-13.96

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$-75M

Net Margin (in %)

Total net margin

$-69M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 11600.40 1376.00 4.95 18.29 43.06
Catalent, Inc. CTLT 10838.26 2872.00 5.44 103.91 3.63
Perrigo Co. Plc PRGO 7561.03 4837.00 1.30 51.58 3.02
Bausch Health Cos., Inc. BHC 6474.02 8597.00 9.03 -3.42 -21.96
Jazz Pharmaceuticals Plc JAZZ 6255.75 2188.00 2.16 22.86 12.81
United Therapeutics Corp. UTHR 5174.19 1443.00 1.80 9.99 36.59
MyoKardia, Inc. MYOK 4329.06 34.00 12.58 -13.96 -201.73
Axsome Therapeutics, Inc. AXSM 2833.95 None 19.23 -31.51 None
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2236.52 9.00 2.63 -3.45 -413.06
Pacira Biosciences, Inc. PCRX 2199.54 435.00 5.90 -5237.00 -0.02
Corcept Therapeutics, Inc. CORT 2095.96 335.00 4.81 19.75 31.64
Prestige Consumer Healthcare, Inc. PBH 1844.67 963.00 1.55 13.01 14.77
Revolution Medicines, Inc. RVMD 1829.59 48.00 4.75 -25.84 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1673.70 0.00 4.47 -16.38 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1598.26 440.00 -22.62 18.85 19.14
Innoviva, Inc. INVA 1580.87 285.00 3.74 8.18 66.41
Intercept Pharmaceuticals, Inc. ICPT 1506.88 272.00 -44.85 -4.39 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1313.55 5.00 3.59 -3.09 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Revance Therapeutics, Inc. RVNC 1181.11 0.00 4.66 -6.33 41.82
Theravance Biopharma, Inc. TBPH 1169.64 88.00 -8.21 -4.74 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1074.08 327.00 2.68 21.08 15.90
Endo International Plc ENDP 795.72 3014.00 -1.09 -2.84 -9.09
BellRing Brands, Inc. BRBR 766.74 954.00 -0.42 5.82 13.98
Eagle Pharmaceuticals, Inc. EGRX 678.44 192.00 3.65 269.22 1.29
Assembly Biosciences, Inc. ASMB 672.22 16.00 3.01 -6.76 -601.75
Aerie Pharmaceuticals, Inc. AERI 642.62 79.00 5.10 -3.18 -252.92
Collegium Pharmaceutical, Inc. COLL 593.64 299.00 4.25 -45.95 -4.21
Anika Therapeutics, Inc. ANIK 537.18 125.00 1.86 19.38 22.73
Catalyst Pharmaceuticals, Inc. CPRX 514.67 119.00 5.01 11.73 36.09
Intersect ENT, Inc. XENT 439.36 102.00 4.15 -8.80 -48.61
BioDelivery Sciences International, Inc. BDSI 408.48 130.00 5.84 -55.50 -5.01
ANI Pharmaceuticals, Inc. ANIP 370.68 203.00 1.90 -237.62 -0.67
Albireo Pharma, Inc. ALBO 337.35 11.00 3.43 -4.41 -730.55
MEI Pharma, Inc. MEIP 289.67 5.00 4.99 -7.43 -539.48
Mallinckrodt Plc MNK 204.12 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 166.97 None 2.72 -8.09 None
Marinus Pharmaceuticals, Inc. MRNS 160.02 0.00 6.20 -2.37 None
Zynerba Pharmaceuticals, Inc. ZYNE 144.90 0.00 2.38 -4.04 -699.94
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 94.38 1.00 66.00 -5.08 None
AcelRx Pharmaceuticals, Inc. ACRX 91.20 2.00 -1.68 -1.63 -644.25
Evoke Pharma, Inc. EVOK 89.28 None 31.00 -13.29 None
Adamas Pharmaceuticals, Inc. ADMS 71.68 57.00 -4.57 -0.77 -160.44
CTI BioPharma Corp. CTIC 69.62 3.00 3.11 -1.69 -111.83
Aclaris Therapeutics, Inc. ACRS 67.65 4.00 1.19 -0.49 None
Oramed Pharmaceuticals, Inc. ORMP 63.36 3.00 5.10 -4.96 -464.15
Cassava Sciences, Inc. SAVA 54.34 41.00 2.86 -11.92 76.71
SCYNEXIS, Inc. SCYX 48.89 0.00 10.27 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.60 47.00 0.99 -10.80 -9.59
Natural Alternatives International, Inc. NAII 48.58 114.00 0.67 -12.85 -3.19
IsoRay, Inc. ISR 37.52 9.00 7.00 -11.20 -36.08
Lipocine, Inc. LPCN 36.90 0.00 8.79 -2.46 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.45 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.99 0.00 -2.68 -2.96 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.00 3.00 2.36 -1.60 -264.21
Regulus Therapeutics, Inc. RGLS 14.49 0.00 1.28 -0.68 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.43 None 1.34 -0.24 None
VIVUS, Inc. VVUS 8.69 73.00 -0.19 -0.29 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.74 19.00 1.07 -2.16 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.68 None 1.77 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.20 None 1.05 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

BRIEF-Myokardia Inc - Plans To Start Phase 2 Genetic Dcm Study In Second Half Of 2020

12d ago, source: Reuters

EXPECTS TO INITIATE PHASE 2 STUDY IN PATIENTS WITH SYSTOLIC HEART FAILURE & PAROXYSMAL OR PERSISTENT ATRIAL FIBRILLATION IN H1 2021 * MYOKARDIA INC - ONE SERIOUS ADVERSE EVENT REPORTED DURING STUDY ...

MyoKardia's Positive Data And Other News: The Good, Bad And Ugly Of Biopharma

Opinion ago, source: Seeking Alpha

MyoKardia's danicamtiv trial yields positive results. Ziopharm completes enrolment for trial of Ad-RTS-hIL-12 with veledimex in combination with Regeneron' Libt ...

Mary B. Cranston Sells 21,629 Shares of Myokardia Inc (NASDAQ:MYOK) Stock

21h ago, source: modernreaders.com

Director Mary B. Cranston sold 21,629 shares of the business’s stock in a transaction dated Tuesday, June 30th. The stock was sold at an average price of $96.60, for a total value of $2,089,361.40.

BidaskClub Lowers Myokardia (NASDAQ:MYOK) to Hold

15h ago, source: theenterpriseleader.com

BidaskClub cut shares of Myokardia (NASDAQ:MYOK) from a buy rating to a hold rating in a research report released on ...

Legal & General Group Plc Has $1.26 Million Stock Holdings in Myokardia Inc (NASDAQ:MYOK)

4d ago, source: theenterpriseleader.com

Legal & General Group Plc decreased its stake in shares of Myokardia Inc (NASDAQ:MYOK) by 6.8% in the 1st quarter, according ...

Notable Monday Option Activity: MYOK, GILD, OSIS

5d ago, source: Nasdaq

Especially high volume was seen for the $77 strike call option expiring July 02, 2020, with 3,104 contracts trading so far ...

Hedge Funds Have Never Been This Bullish On Franklin Electric Co., Inc. (FELE)

5d ago, source: Insider Monkey

In this article we will take a look at whether hedge funds think Franklin Electric Co., Inc. (NASDAQ:FELE) is a good investment right now. We check hedge fund and billionaire investor sentiment ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.